Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 1 , Pages 103-109, February 2010

Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria

  • Amanulla Mohammed Fayaz, PhD

      Affiliations

    • CAS in Botany, University of Madras, Guindy Campus, Chennai, India
    • Corresponding Author InformationCorresponding author: CAS in Botany, University of Madras, Guindy Campus, Chennai 600 025, India.
  • ,
  • Kulandaivelu Balaji, PhD

      Affiliations

    • Orchid Healthcare (A division of Orchid Chemicals & Pharmaceuticals Ltd.), Chennai, India
  • ,
  • Morukattu Girilal, PhD

      Affiliations

    • CAS in Botany, University of Madras, Guindy Campus, Chennai, India
  • ,
  • Ruchi Yadav, MTech

      Affiliations

    • Department of Bioinformatics, Sathyabama University, Chennai, India
  • ,
  • Pudupalayam Thangavelu Kalaichelvan, PhD

      Affiliations

    • CAS in Botany, University of Madras, Guindy Campus, Chennai, India
  • ,
  • Ramasamy Venketesan, PhD

      Affiliations

    • Ocean and Science Technology for Islands, National Institute of Ocean Technology, Chennai, India

Received 15 July 2008; accepted 23 April 2009. published online 18 May 2009.

Abstract 

The development of a reliable green chemistry process for the biogenic synthesis of nanomaterials is an important aspect of current nanotechnology research. Silver nanoparticles (AgNPs) have been known for their inhibitory and bactericidal effect. Resistance to antimicrobial agents by pathogenic bacteria has emerged in recent years and is a major challenge for the health care industry. In the present investigation the use of the fungus Trichoderma viride for the extracellular biosynthesis of AgNPs from silver nitrate solution is reported. It was observed that the aqueous silver (Ag+) ions, when exposed to a filtrate of T. viride, were reduced in solution, thereby leading to formation of extremely stable AgNPs. These AgNPs were characterized by means of several techniques. The nanoparticles show maximum absorbance at 420 nm on ultraviolet-visible spectra. The presence of proteins was identified by Fourier transform–infrared spectroscopy. The reduction of Ag+ ions to elemental silver was characterized by x-ray photoelectron spectrophotometry. Electrokinetic measurements (zeta potential) of AgNPs as a function of pH in 1 × 10−3 mol dm−3 aqueous solution were evaluated. The transmission electron micrograph revealed the formation of polydispersed nanoparticles of 5–40 nm, and the presence of elemental silver was confirmed by energy-dispersed spectroscopy analysis. The nanoparticles were also evaluated for their increased antimicrobial activities with various antibiotics against gram-positive and gram-negative bacteria. The antibacterial activities of ampicillin, kanamycin, erythromycin, and chloramphenicol were increased in the presence of AgNPs against test strains. The highest enhancing effect was observed for ampicillin against test strains. The result showed that the combination of antibiotics with AgNPs have better antimicrobial effects. A mechanism was also proposed to explain this phenomenon.

From the Clinical Editor

Silver nanoparticles (Ag NP-s) represent an important nanomedicine-based advance in the fight against polyresistent bacteria. In this study, the fungus Trichoderma viride was utilized for extracellular biosynthesis of extremely stable Ag Nps. The antibacterial activities of kanamycin, erythromycin, chloramphenicol and especially of ampicillin were increased in the presence of Ag NPs against test strains.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 No conflict of interest was reported by the authors of this article.

PII: S1549-9634(09)00091-4

doi:10.1016/j.nano.2009.04.006

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 1 , Pages 103-109, February 2010